Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PEG-asparaginase During Two Treatment Courses in the Treatment of Childhood Acute Lymphoblastic Leukemia

NCT00192673 is registered in ClinicalTrials.gov with Nordic Society for Pediatric Hematology and Oncology as lead sponsor.

NCT NCT00192673
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00192673 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PEG-asparaginase During Two Treatment Courses in the Treatment of Childhood Acute Lymphoblastic Leukemia
Lead sponsor
Nordic Society for Pediatric Hematology and Oncology
Phase
Phase 4
Overall status
Unknown status
Start date
June 30, 2005
Completion date
December 31, 2013
Enrollment
85 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia